Skip to content
Dose Brief
Menu
The shortlist

Alternatives to The Edit

The Edit sits at No. 65 in our ranking with a Brief Score of 78. Here are the GLP-1 providers we'd weigh against it — ranked on the same six-factor Brief Score, top down.

Prefer a straight head-to-head? CoreAge Rx vs The Edit.

Our top alternative

No. 1 here

CoreAge Rx

CoreAge publishes different starting offers across its pages; the advertised annual rates require a full year paid upfront.

Semaglutide

From $79/mo

Annual offer: 12 months paid upfront, from $948.

Main site: from $99/mo; confirm the selected offer.

Full price details

From $79/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($948 at that starting rate); main product page separately advertises from $99/mo

Tirzepatide

From $129/mo

Annual offer: 12 months paid upfront, from $1,548.

Main site: from $149/mo; confirm the selected offer.

Full price details

From $129/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($1,548 at that starting rate); main product page separately advertises from $149/mo

Coverage
US only; restrictions by state, confirmed at intake
Visit CoreAge Rx CoreAge Rx vs The Edit →

More providers worth weighing

No. 10 · Grade B

Enhance MD

85/100

A transparent, tiered compounding provider that lays out every price on the ladder up front — semaglutide, tirzepatide, microdose, and a combo line — with NAD+ care sitting alongside.

Semaglutide

$249 every 4 weeks month-to-month (13 charges a year); $212/mo only on the 12-month prepay

Coverage
Not publicly listed
Price trend
price stable
Visit Read the brief →
No. 38 · Grade B

Peak Wellness

83/100

Peak Wellness names its clinical group and pharmacy network, but starting offers, prepaid plans and early renewal rules need to be compared together.

Semaglutide

Confirm current price

Earlier listing: $249/mo (original check date not recorded).

Confirm the medication, billing term and full charge before paying.

Full price details

Compounded semaglutide offered. Current medication quote unknown; earlier listing: $249/mo

Coverage
All 50 states
Price trend
price stable
Visit Read the brief →
No. 112 · Grade C

AHBARx

73/100

AHBARx publishes clear medication-plan charges, but its general terms conflict with the no-membership-fee message and need clarification.

Semaglutide

Confirm membership charges

Semaglutide: $249 for one month; $649 upfront for three months or $1,199 for six. Separate membership terms conflict with no-fee messaging.

Full price details

Complete quote unknown because membership terms conflict; compounded semaglutide advertised $249/month, $649 upfront for 3 months or $1,199 for 6 months

Coverage
US patient location required; confirm state-specific clinician and pharmacy availability
Price trend
new to the tracker, no prior reading
Visit Read the brief →
No. 9 · Grade B+

Invigor Medical

88/100

Invigor Medical now redirects to Try Invigor, which advertises compounded GLP-1 programs with an early cancellation cutoff and prescription-specific pricing.

Semaglutide

GLP-1 program from $225

Confirm the named medication, supply period and final total.

Full price details

GLP-1 treatment advertised from $225; named medication, supply period and complete quote require confirmation

Coverage
Site advertises clinicians licensed in 50 states; confirm the treatment and dispensing availability in your state
Price trend
new to the tracker, no prior reading
Visit Read the brief →
No. 228 · Grade C

WePeptideRx

67/100

WePeptideRx is a provider-guided telehealth platform offering compounded semaglutide and tirzepatide alongside a deep menu of peptide, hormone, hair, and sexual-wellness programs.

Semaglutide

From $249/mo (compounded)

Coverage
Coverage not published
Price trend
new to the tracker, no prior reading
Visit Read the brief →
No. 242 · Grade C

Luma Meds

66/100

Fully online compounded GLP-1 telehealth offering semaglutide and tirzepatide injections from FDA-regulated 503A and 503B compounding pharmacies.

Semaglutide

From $249/mo (compounded)

Coverage
Coverage not published
Price trend
new to the tracker, no prior reading
Visit Read the brief →
No. 287 · Grade C

Lean Rx

64/100

LeanRx lists starting prices, but shipping, higher-dose vial charges and a recurring-plan commitment matter before payment.

Semaglutide

From $266; plan duration unconfirmed

Recurring plan: four-week billing, initial 24-week/six-vial commitment. Twelve-/forty-eight-week prepaid plans offered; shipping $35 unless qualifying waiver. Consultation $1 advertised alongside free-consult language.

Provider-approved higher-dose extra vial $150 every four weeks. Prescription/service payments broadly nonrefundable; obtain full quote, concentration and renewal-stop terms.

Full price details

Compounded semaglutide injection offered; complete selected-plan quote unknown; homepage starting figure $266 without confirmed plan duration, $1 consultation advertised, shipping and higher-dose vial terms depend on plan

Coverage
FAQ-linked map marks selected states licensed and others coming soon; Florida, Illinois and Tennessee are shown coming soon, so confirm actual patient-state access
Price trend
new to the tracker, no prior reading
Visit Read the brief →
No. 271 · Grade C

WeightRx

65/100

WeightRx advertises low starting figures, but long-plan nonrefund terms, a processing-fee clause and coming-soon brands need careful comparison.

Semaglutide

Confirm full selected-plan quote

$250/month card does not establish exact formulation, complete term, initial charge or supplied quantity.

All listed plan lengths auto-renew; six- and twelve-month nonrefund rules and refund deductions need clarification.

Full price details

Semaglutide listed; exact formulation and complete selected-plan quote unknown; $250/month card lacks full term and supply conditions

Coverage
U.S. patients subject to independent clinician review; complete medication-specific state and pharmacy eligibility are not established
Price trend
new to the tracker, no prior reading
Visit Read the brief →
Read our full The Edit brief →All comparisons →

Rankings reflect the Dose Brief Score — our editorial judgment per the methodology. Pricing and coverage reflect public disclosures at last review and change often — confirm on each provider's site. Not medical advice; see our disclosure.